We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Review · August 15, 2022

Additional Clinical Benefit of Topical Minoxidil at Concentrations Higher Than 5% in Patients With Androgenetic Alopecia

Clinical and Experimental Dermatology

 

Additional Info

Clinical and Experimental Dermatology
Does topical minoxidil in concentrations higher than 5% provide additional clinical benefit?
Clin Exp Dermatol 2022 Jul 26;[EPub Ahead of Print], M Goldust, S Singh, A Patil, N Kianfar, A Waskiel-Burnat, L Rudnicka, R Sinclair

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading